Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia

Abstract

The posterior cingulate cortex (PCC) has recently been implicated in the pathophysiology of schizophrenia, through both animal and human studies. We have recently shown abnormal glutamate, GABA, and muscarinic receptor binding in the PCC in schizophrenia. In addition, there is evidence for an abnormal endogenous cannabinoid system in schizophrenia. The… (More)
DOI: 10.1007/s00221-006-0503-x

2 Figures and Tables

Topics

  • Presentations referencing similar topics